PT906303E - Dihidropiranos de aneis geminados, processo para a sua producao bem como a sua utilizacao - Google Patents

Dihidropiranos de aneis geminados, processo para a sua producao bem como a sua utilizacao

Info

Publication number
PT906303E
PT906303E PT97928221T PT97928221T PT906303E PT 906303 E PT906303 E PT 906303E PT 97928221 T PT97928221 T PT 97928221T PT 97928221 T PT97928221 T PT 97928221T PT 906303 E PT906303 E PT 906303E
Authority
PT
Portugal
Prior art keywords
geminiated
dihidropiranes
rings
production
compounds
Prior art date
Application number
PT97928221T
Other languages
English (en)
Inventor
Stephan Henke
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT906303E publication Critical patent/PT906303E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Peptides Or Proteins (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT97928221T 1996-06-18 1997-06-18 Dihidropiranos de aneis geminados, processo para a sua producao bem como a sua utilizacao PT906303E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19624154A DE19624154A1 (de) 1996-06-18 1996-06-18 Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung

Publications (1)

Publication Number Publication Date
PT906303E true PT906303E (pt) 2003-08-29

Family

ID=7797180

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97928221T PT906303E (pt) 1996-06-18 1997-06-18 Dihidropiranos de aneis geminados, processo para a sua producao bem como a sua utilizacao

Country Status (11)

Country Link
US (1) US6399653B1 (pt)
EP (1) EP0906303B1 (pt)
JP (1) JP4181219B2 (pt)
AT (1) ATE236895T1 (pt)
AU (1) AU3259997A (pt)
CA (1) CA2258539C (pt)
DE (2) DE19624154A1 (pt)
DK (1) DK0906303T3 (pt)
ES (1) ES2193380T3 (pt)
PT (1) PT906303E (pt)
WO (1) WO1997048691A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6137560A (en) 1995-10-23 2000-10-24 Hitachi, Ltd. Active matrix type liquid crystal display apparatus with light source color compensation
IL143094A0 (en) * 1998-12-02 2002-04-21 Pfizer Prod Inc METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
MEP17008A (en) * 2004-02-20 2010-06-10 Aventis Pharma Inc Oxydecahydronaphthalene modulators of hm74
US7750015B2 (en) * 2005-05-17 2010-07-06 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
AU2006247695B2 (en) * 2005-05-17 2012-08-09 Merck Sharp & Dohme Corp. Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
PE20070854A1 (es) * 2006-01-20 2007-09-10 Schering Corp Compuestos heterociclos como agonistas del receptor de acido nicotinico
US11932655B1 (en) 2023-10-17 2024-03-19 King Faisal University 12-bromo-2,16-dioxapentacyclo[7.7.5.01,21.03,8.010,15]henicosa3(8),10,12,14-tetraene-7,20-dione as an antimicrobial compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3775435A (en) * 1971-08-26 1973-11-27 American Home Prod 5,6,7,8-tetrahydro-2,5(and 4,5)-dioxo-1-benzopyrans
GB9318431D0 (en) 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
DE19624154A1 (de) 1998-01-08
CA2258539C (en) 2009-06-02
JP4181219B2 (ja) 2008-11-12
US6399653B1 (en) 2002-06-04
ES2193380T3 (es) 2003-11-01
EP0906303A1 (de) 1999-04-07
AU3259997A (en) 1998-01-07
CA2258539A1 (en) 1997-12-24
DE59709792D1 (de) 2003-05-15
EP0906303B1 (de) 2003-04-09
ATE236895T1 (de) 2003-04-15
JP2000512305A (ja) 2000-09-19
WO1997048691A1 (de) 1997-12-24
DK0906303T3 (da) 2003-07-28

Similar Documents

Publication Publication Date Title
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
BR0112786A (pt) Inibidores de inflamação não-esteroidais
MX9304649A (es) Procedimiento para producir 7-(sustituido)-9-[glicilo sustituido]-6-desmetil-6-desoxitetraciclinas.
BR0017030A (pt) Derivados de tiazolilamida
BR9506667A (pt) Composto intermediário de cloro-pirimidina processo para a preparação do composto intermediário de cloro-pirimidina processo para a preparação de 2,5-diamino-4,6-dicloro-pirimidina processo para a preparação de 2,6-diamino-purinas e processo para a preparação de (1s,4s)-4-2-amino-6-(ciclo-propil-amino)-9h-purin-9-il¾-2-ciclo-penteno-1-metanol
BR0017043A (pt) Imidazo[1,3,5]triazinonas e sua aplicação
DK0859766T3 (da) Chirale methylphenyloxazolidinoner
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
BR0311940A (pt) Difenilazetidinonas substituìdas no anel, processo para produção das mesmas, medicamentos que contêm esses compostos e uso dos mesmos
ECSP045497A (es) "difenilazetidinonas sustituidas con grupos acidos, metodo para su producción, medicamentos que comprenden dichos compuestos y su uso"
EA199900279A1 (ru) Производные бензамида и их применение в качестве лекарственных средств с лтв4-антагонистической активностью
ES2149157T3 (es) Nuevo procedimiento para la preparacion de nucleotidos.
PT906303E (pt) Dihidropiranos de aneis geminados, processo para a sua producao bem como a sua utilizacao
BR0312863A (pt) Derivados de aldeìdo de polietileno glicol
ID26210A (id) Proses pemurnian turunan sefalosporin
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
BR0012622A (pt) Derivados de 3-amino-2-benzil-1-fenil-propano
PT1001961E (pt) Derivados substituidos de tetra-hidropirano bem como processo para a sua preparacao
BRPI0013751B8 (pt) processo para produção de derivados de ácido naftiridina-3-carboxílico.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
MX9300335A (es) Nuevas n-arilindolas y su uso como herbicidas.
ATE226585T1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
ATE446952T1 (de) Herstellungsverfahren von 2-cyanopyridinen